SOURCES SOUGHT
A -- Clinical Trials Network Pharmacy Support
- Notice Date
- 2/20/2003
- Notice Type
- Sources Sought
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Blvd. Room #3105, Bethesda, MD, 20892-9543
- ZIP Code
- 20892-9543
- Solicitation Number
- N01DA-3-2203
- Archive Date
- 3/22/2003
- Point of Contact
- David Lisle, Contract Specialist, Phone (301) 443-6677, Fax (301) 443-7595, - Nikki Zangwill, Contracting Officer, National Institute on Drug Abuse, NIH, Phone (301) 443-6677, Fax (301)443-7595,
- E-Mail Address
-
dl115q@nih.gov, nz2f@nih.gov
- Small Business Set-Aside
- Total Small Business
- Description
- The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified small businesses to provide resources to support the pharmacy needs of the Center for the Clinical Trials Network (CCTN). In an effort to dramatically improve drug abuse treatment throughout the country, NIDA established the CCTN in September 1999 and has awarded fourteen Regional Research and Training Centers (RRTCs). Each RRTC has contractual agreement with 5-8 Community-based Treatment Programs (CTPs). Multi-site clinical trials will be conducted in these community program sites. This contract is to support the work of the CCTN in its conducting of clinical trials to evaluate the effectiveness of science-based behavior therapies and/or safe and effective medication therapies. No actual clinical or laboratory studies will be conducted under this contract. The Contractor shall be required to purchase and package medications and other clinical supplies as specified in each Government-provided protocol. The Contractor must have a full range of drug storage and distribution services. The Contractor must have an automated tracking system for all packaging, nation-wide shipping, and inventory services. The Contractor must have the capability to research, develop and perform qualitative and quantitative analysis for trial medications. The Contractor must posses Drug Enforcement Agency (DEA) registrations to handle Class I through V controlled substances and established standard operating procedures performed under current Good Manufacturing Practice (cGMP) and Good Laboratory Practice (GLP) guidelines.
- Record
- SN00262050-W 20030222/030220213246 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |